|Study Description:||The goal of this clinical research study is to learn if BKM120 (buparlisib) can |
help to control glioblastoma and/or gliosarcoma. Researchers also want to
learn more about how much study drug is in different areas of the body at
different time points. The safety of this drug will also be studied.
BKM120 is designed to block a protein that is important to the growth and
division of cancer cells, which may cause the cells to die.